INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 265 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,729,900 | +201.6% | 110,000 | +266.7% | 0.09% | +158.8% |
| Q2 2023 | $1,899,600 | -41.5% | 30,000 | -50.0% | 0.03% | -45.2% |
| Q1 2023 | $3,249,000 | +109.5% | 60,000 | +104.7% | 0.06% | +158.3% |
| Q4 2022 | $1,550,821 | +40.0% | 29,305 | +23.1% | 0.02% | +60.0% |
| Q3 2022 | $1,108,000 | -85.8% | 23,805 | -82.6% | 0.02% | -86.1% |
| Q2 2022 | $7,826,000 | -63.6% | 137,100 | -66.7% | 0.11% | -55.2% |
| Q4 2021 | $21,529,000 | +235.4% | 411,344 | +138.9% | 0.24% | +230.1% |
| Q3 2021 | $6,419,000 | +20.6% | 172,179 | +32.1% | 0.07% | +5.8% |
| Q2 2021 | $5,321,000 | +41.3% | 130,360 | +17.4% | 0.07% | -14.8% |
| Q1 2021 | $3,765,000 | +92.5% | 111,000 | +80.5% | 0.08% | +80.0% |
| Q4 2020 | $1,956,000 | +27.8% | 61,500 | +3.1% | 0.04% | +25.0% |
| Q3 2020 | $1,531,000 | -94.6% | 59,673 | -94.6% | 0.04% | -96.2% |
| Q2 2020 | $28,196,000 | +1155.4% | 1,098,450 | +651.8% | 0.94% | +639.4% |
| Q1 2020 | $2,246,000 | -97.0% | 146,100 | -93.4% | 0.13% | -95.0% |
| Q4 2019 | $75,392,000 | +652.0% | 2,197,300 | +63.7% | 2.53% | +385.2% |
| Q3 2019 | $10,026,000 | +82.2% | 1,342,100 | +216.5% | 0.52% | +88.4% |
| Q2 2019 | $5,502,000 | +40.5% | 424,000 | +31.9% | 0.28% | +28.2% |
| Q1 2019 | $3,917,000 | – | 321,500 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |